Safety of Zileuton (Zyflo) in Combination With Imatinib Mesylate (Gleevec) in CML.

NCT01130688 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Lack of enrollment

Conditions

Chronic Myelogenous Leukemia

Interventions

DRUG: Zileuton

Sponsor

University of Massachusetts, Worcester